MHRA – Page 203 – Pharma.Tips

Media Fill Failure during method transfer: packaging integrity and CCIT justification

Analyzing Media Fill Failure During Method Transfer: Ensuring Packaging Integrity and CCIT Justification The pharmaceutical manufacturing environment is fraught with complexities, especially when ensuring product sterility through media fill processes.…

Filter Integrity Failure during aseptic filling: data integrity checks for lab and shop floor

Addressing Filter Integrity Failures During Aseptic Filling: A Comprehensive Investigation Approach In pharmaceutical manufacturing, particularly in aseptic filling processes, the integrity of filters is critical to ensuring product quality and…

Smoke Study Failure after maintenance intervention: FDA/MHRA investigation narrative and batch impact

Analyzing Smoke Study Failures Post-Maintenance Interventions: An Investigation Framework In the complex arena of pharmaceutical manufacturing, disturbances in routine processes due to maintenance interventions can lead to significant failures, such…

Fill Volume Variability at stability pull: risk assessment for sterility assurance

Investigating Fill Volume Variability during Stability Pulls in Ophthalmic Manufacturing Fill volume variability during stability pulls can pose a significant risk to sterility assurance in pharmaceutical manufacturing, particularly in ophthalmic…

Filter Integrity Failure during campaign changeover: CAPA package with evidence and effectiveness checks

Investigation of Filter Integrity Failures during Campaign Changeovers in Pharmaceutical Manufacturing Filter integrity failures during campaign changeovers can disrupt production lines, compromise product quality, and initiate regulatory scrutiny. Such incidents…

Endotoxin Oos during campaign changeover: data integrity checks for lab and shop floor

Investigating Endotoxin OOS in Campaign Changeovers: Ensuring Data Integrity on the Lab and Shop Floor In the pharmaceutical manufacturing sector, one of the critical challenges encountered during campaign changeovers is…

Ccit Failure at stability pull: risk assessment for sterility assurance

Ccit Failure During Stability Testing: A Comprehensive Risk Assessment for Sterility Assurance Pharmaceutical manufacturing environments are rigorously regulated, with an emphasis on ensuring product quality and patient safety. Among the…

Sterility Test Failure during terminal sterilization: how to classify deviation and set disposition

Sterility Test Failure During Terminal Sterilization: Classifying Deviation and Setting Disposition In the highly regulated environment of pharmaceutical manufacturing, sterility test failures during terminal sterilization processes present a significant challenge.…

Media Fill Failure during PAI readiness: how to classify deviation and set disposition

How to Address Media Fill Failures during PAI Readiness: A Structured Approach to Deviation Classification and Disposition In the pharmaceutical industry, media fill failures can pose significant challenges during process…

Ph Drift after packaging change: FDA-ready investigation report and batch disposition

Addressing pH Drift Following a Packaging Change: A Comprehensive Investigation Framework In pharmaceutical manufacturing, a deviation in pH levels post-packaging can signal underlying issues that could impact product quality and…

Media Fill Failure during routine EM trending: FDA/MHRA investigation narrative and batch impact

Understanding Media Fill Failures in Routine Environmental Monitoring: A Comprehensive FDA/MHRA Investigation Guide Media fill failures during routine environmental monitoring (EM) can pose significant challenges to pharmaceutical manufacturers, especially in…

Filter Integrity Failure during hold-time study: FDA/MHRA investigation narrative and batch impact

Investigation of Filter Integrity Failures during Hold-Time Studies in Pharmaceutical Manufacturing During routine quality control activities, a filter integrity failure was recorded during a hold-time study for parenteral dosage forms.…